Patch for treating bronchial asthma of children

A pediatric asthma and patch technology, applied in the field of patches for treating pediatric asthma, can solve the problems of caking and mildew, affecting the curative effect, and being susceptible to moisture, and achieves the effect of preventing recurrence, significant curative effect, and easy acceptance.
CN102085337AInactive Publication Date: 2011-06-08XIANGYU PHARMA

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
XIANGYU PHARMA
Publication Date
2011-06-08
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The invention discloses a patch for treating bronchial asthma of children. The patch comprises a medicinal composition, and the medicinal composition is prepared from the following components in part by weight: 10 to 30 parts of Chinese ephedra, 10 to 30 parts of white mustard seed, 1 to 15 parts of clove, 15 to 45 parts of Japanese ardisia, 5 to 20 parts of wild ginger and 10 to 30 parts of ginger. Clinical tests show that the patch do not cause any reverse reaction and have obvious curative effect; after patients use the patch, the bodies of the patients are obviously strengthened, which means that the product has the effect of enhancing the immunity of organisms. When the Xiangmahanchuan patch is applied to acupuncture points, the patch can achieve the effects of obviously treating asthma, enhancing the body of children suffering asthma and preventing the recurrence of asthma.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to traditional Chinese medicine patches, in particular to a patch for treating children's asthma. Background technique

[0002] Asthma and bronchitis in children are common and frequently-occurring diseases in pediatric clinics, which not only endanger children's health, but also cause huge economic burdens to families and society. According to data reports, the prevalence rate of childhood asthma in my country is 0.5% to 2%, and it is as high as 5% in some places. There are about 20 to 40 million children in the country. Modern medicine believes that bronchial asthma is a respiratory hyperresponsive disease caused by hypersensitivity. In terms of drug treatment, it is emphasized that according to the needs of the condition, in addition to the use of antispasmodic and antiasthmatic drugs (symptomatic treatment), anti-airway allergic inflammation drugs should also be used in combination (etiological treatment). Glucocorticoid (GCS...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More